ANDA 212722

PharmaQ, Inc.

FDA Drug Application

Application #212722

Documents

• Letter: 2020-09-22

Application Sponsors

ANDA 212722

PharmaQ, Inc.

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET; ORAL	267MG	0	PIRFENIDONE	PIRFENIDONE
002	TABLET; ORAL	534MG	0	PIRFENIDONE	PIRFENIDONE
003	TABLET;ORAL	801MG	0	PIRFENIDONE	PIRFENIDONE

FDA Submissions

UNKNOWN;

ORIG

1

TA

2020-08-28

STANDARD

Submissions Property Types

ORIG

1

Null

31

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

PharmaQ, Inc.

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212722
            [companyName] => PharmaQ, Inc.
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIRFENIDONE","activeIngredients":"PIRFENIDONE","strength":"267MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"PIRFENIDONE","activeIngredients":"PIRFENIDONE","strength":"534MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"PIRFENIDONE","activeIngredients":"PIRFENIDONE","strength":"801MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/28\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/212722Orig1s000TA_ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-28
        )

)